Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

FastMix: A Versatile Multi-Omics Data Integration Pipeline for Cell Type-Specific Biomarker Inference

View ORCID ProfileYun Zhang, Hao Sun, Aishwarya Mandava, Brian D. Aevermann, Tobias R. Kollmann, Richard H. Scheuermann, View ORCID ProfileXing Qiu, Yu Qian
doi: https://doi.org/10.1101/2021.09.14.21263182
Yun Zhang
1Informatics, J. Craig Venter Institute, La Jolla, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yun Zhang
Hao Sun
2Biostatistics and Computational Biology, University of Rochester, Rochester, NY, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aishwarya Mandava
1Informatics, J. Craig Venter Institute, La Jolla, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian D. Aevermann
1Informatics, J. Craig Venter Institute, La Jolla, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias R. Kollmann
3Telethon Kids Institute, Perth Children’s Hospital, University of Western Australia; Nedlands, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard H. Scheuermann
1Informatics, J. Craig Venter Institute, La Jolla, CA, United States
4Pathology, University of California, San Diego, La Jolla, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing Qiu
2Biostatistics and Computational Biology, University of Rochester, Rochester, NY, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xing Qiu
  • For correspondence: xing_qiu{at}urmc.rochester.edu mqian{at}jcvi.org
Yu Qian
1Informatics, J. Craig Venter Institute, La Jolla, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xing_qiu{at}urmc.rochester.edu mqian{at}jcvi.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We developed a novel analytic pipeline - FastMix - to integrate flow cytometry, bulk transcriptomics, and clinical covariates for statistical inference of cell type-specific gene expression signatures. FastMix addresses the “large p, small n” problem via a carefully designed linear mixed effects model (LMER), which is applicable for both cross-sectional and longitudinal studies. With a novel moment-based estimator, FastMix runs and converges much faster than competing methods for big data analytics. The pipeline also includes a cutting-edge flow cytometry data analysis method for identifying cell population proportions. Simulation studies showed that FastMix produced smaller type I/II errors with more accurate parameter estimation than competing methods. When applied to real transcriptomics and flow cytometry data in two vaccine studies, FastMix-identified cell type-specific signatures were largely consistent with those obtained from the single cell RNA-seq data, with some unique interesting findings.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT03083158

Funding Statement

This work is partially funded by NIH/NIAID UH2AI132342, the Human Vaccines Project, the Respiratory Pathogens Research Center (NIAID contract number HHSN272201200005C) and the University of Rochester CTSA award number UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of British Columbia Human Research Ethics Committee and Internal Review Board (IRB) have provided approval for the clinical trial NCT03083158 (PI: Tobias Kollmann; Title: Identification of Age-dependent Mechanism of Vaccine-induced Immunity to a Single Dose of Hepatitis B Vaccine Using a Systems Biology Approach - a Demonstration Project). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. For SDY180, data are publicly available after registration with ImmPort.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The HVP01 dataset (https://clinicaltrials.gov/ct2/show/NCT03083158) is a clinical study conducted by University of British Columbia focused on Hepatitis B vaccine Engerix-B. This study has 16 healthy subjects from two cohorts: young adults (aged 40-60) and old adults (aged 61-80). Both RNA-seq gene expressions and flow cytometry data are available across multiple visits before and after the vaccination from the same whole blood samples. Primary outcome of this study is the antibody response to the first dose of Hepatitis B vaccine. The SDY180 dataset is downloaded from the ImmPort Shared Data portal (http://www.immport.org). This study has 18 young and healthy adult volunteers (aged 18-64) randomly assigned to three study groups (n = 6 subjects/group) receiving a single intramuscular dose of 2009-2010 seasonal influenza (Fluzone, Sanofi Pasteur, PA), pneumococcal vaccine (Pneumovax23, Merck, NJ), or placebo (saline). Blood samples were collected at multiple time visits, from 7 days before vaccination to 28 days after vaccination, for microarray, whole-blood flow cytometry, and serum analysis of neutralizing antibodies. Data preprocessing details are in Supplementary Material.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 27, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
FastMix: A Versatile Multi-Omics Data Integration Pipeline for Cell Type-Specific Biomarker Inference
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
FastMix: A Versatile Multi-Omics Data Integration Pipeline for Cell Type-Specific Biomarker Inference
Yun Zhang, Hao Sun, Aishwarya Mandava, Brian D. Aevermann, Tobias R. Kollmann, Richard H. Scheuermann, Xing Qiu, Yu Qian
medRxiv 2021.09.14.21263182; doi: https://doi.org/10.1101/2021.09.14.21263182
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
FastMix: A Versatile Multi-Omics Data Integration Pipeline for Cell Type-Specific Biomarker Inference
Yun Zhang, Hao Sun, Aishwarya Mandava, Brian D. Aevermann, Tobias R. Kollmann, Richard H. Scheuermann, Xing Qiu, Yu Qian
medRxiv 2021.09.14.21263182; doi: https://doi.org/10.1101/2021.09.14.21263182

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)